免疫測量市場：策略與趨勢—按應用、技術、產品、使用者和國家分類的預測—面向高階主管和顧問，人工智慧 (AI) 的影響 (2026–2030)

報告摘要：

免疫測量是診斷產業的基石，如今正開闢新的發展道路。疫情催生了對快速便捷診斷方法的新需求，免疫測量恰好滿足了這項需求。然而，機會與挑戰並存。遺傳學知識的進步正在為免疫測量創造新的市場。多重檢測技術正成為不可或缺的關鍵要素。快速診斷、照護現場、生物標記以及消費市場等許多領域都在影響傳統的免疫測量。本報告分析了該領域80多家公司。歡迎閱讀這份詳盡的報告，探索所有挑戰與機會。

如有需要，報告中的所有資料均可提供 Excel 格式。

利用最新數據，您可以自信地做出投資決策並評估公司估值。

目錄

第1章 市集指南

• 免疫檢測市場—策略情勢分析
• 企業主管、行銷負責人、銷售負責人和業務拓展負責人。
• 管理顧問和投資顧問指南
• 人工智慧的影響

第2章：引言與市場定義

• 本報告中免疫檢測市場的定義
  • 基於酵素的
  • 螢光
  • 化學冷光
  • DNA/NAT
  • RIA 和其他
  • 試劑和試劑盒、分析儀器、軟體和服務
  • 感染疾病
  • 自體免疫
  • 內分泌學
  • 腫瘤學
  • 心臟病學
  • 其他專業領域
• 市場定義
• 調查方法
• 展望：醫療保健和體外診斷產業

第3章 行業概覽

• 參與企業充滿活力的市場
  • 學術研究辦公室
  • 診斷測試開發人員
  • 測量儀器供應商
  • 化學品/試劑供應商
  • 病理檢測用品供應商
  • 獨立臨床實驗室
  • 國家/地區公共研究機構
  • 醫院檢查室
  • 醫師診所檢查室（POLS）
  • 審計機構
  • 認證機構
• 臨床檢測市場細分
• 免疫測量—市場趨勢與分析

第4章 市場趨勢

• 成長促進因素
• 成長阻礙因素
• 免疫測量裝置

第5章：免疫測量的最新進展

第6章：主要企業概況

• Abbott Laboratories
• Abcam
• Abionic
• Accel Diagnostics
• Agilent
• Akonni Biosystems
• Applied BioCode
• Arlington Scientific
• Arrayit Corporation
• Atomo Diagnostics
• Aureum Diagnostics
• Aurora Biomed
• Autobio Diagnostics
• AVIVA Systems Biology
• Awareness Technology
• Axis-Shield Diagnostics Ltd.
• Beckman Coulter Diagnostics（Danaher）
• Becton, Dickinson and Company
• Biocartis
• Biomatik
• bioMerieux Diagnostics
• Bioneer Corporation
• Bio-Rad Laboratories, Inc.
• Bio-Synthesis
• Bio-Techne
• Boditech Med, Inc
• Boster Biological Technology
• Bruker
• Cerstest Biotec
• Chembio
• CTK Biotech
• Cue Health
• Cytena
• Diasorin SpA
• Dynex Technologies
• Eiken Chemical
• Enzo Biochem
• Eurofins Scientific
• Fluxion Biosciences（Cell Microsystems）
• FUJIFILM Wako Diagnostics
• Fujirebio
• Global Access Diagnostics
• Gold Standard Diagnostics
• Greiner Bio-One
• Grifols
• Hycor Biomedical
• Immunodiagnostic Systems（IDS）
• Iollo
• JR Biomedical
• LightDeck Diagnostics
• LumiraDx
• Maxim Biomedical
• Meso Scale Discovery
• Millipore Sigma
• Mindray
• Molecular Devices
• MP Biomedical
• Operon
• OraSure Technologies
• Qiagen
• QuidelOrtho
• R&D Systems
• Randox Toxicology
• R-Biopharm AG
• Response Biomedical
• Revvity
• Roche Diagnostics
• SD Biosensor
• Siemens Healthineers
• Standard BioTools
• Sysmex
• Tecan
• Thermo Fisher Scientific
• TOSOH Bioscience
• Uniogen
• Veramarx
• Veredus Laboratories
• Vircell
• Wantai Biopharm
• Werfen
• YD Diagnostics
• Zhejiang Orient Gene Biotech

第7章：全球市場

• 全球市場（按國家/地區分類）
• 全球市場按應用領域分類
• 全球技術市場
• 全球產品市場
• 全球用戶市場

第8章 按應用程式分類的世界市場

• 內分泌學
• 免疫
• 腫瘤學
• 感染疾病
• 心臟病學
• 其他

第9章 技術世界市場

• 酵素
• 螢光
• 化學冷光
• 核酸
• 快速/即時檢測
• 其他

第10章 世界產品市場

• 裝置
• 試劑
• 服務

第11章：按用戶分類的全球市場

• 醫院
• 門診檢查室
• 負責人/其他

第12章：免疫測量的未來

第13章附錄

表格一覽

圖表列表

Report Overview:

The workhorse of the diagnostic industry is finding new legs. The pandemic has created a new demand for rapid easily available diagnostics. Immunoassay is stepping up. Threats and opportunities abound. Advances in genetic knowledge are creating new markets for immunoassay. Multiplex is becoming table stakes. Rapid diagnostics, point of care, biomarkers and consumer markets are all areas affecting traditional immunoassay. We profile over 80 companies, working in this area. Learn all about the pitfalls and opportunities in this extensive report.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

Table of Contents

1 Market Guides

• 1.1 Immunoassay Market - Strategic Situation Analysis
• 1.2 Guide for Executives, Marketing, Sales and Business Development Staff
• 1.3 Guide for Management Consultants and Investment Advisors
• 1.4 Impact of Artificial Intelligence

2 Introduction and Market Definition

• 2.1 Immunoassay Markets Definition In This Report
  • 2.1.1 Enzyme Based
  • 2.1.2 Immunofluorescence
  • 2.1.3 Chemiluminescence
  • 2.1.4 DNA/NAT
  • 2.1.5 RIA & Other
  • 2.1.6 Reagents/Kits, Analyzers, Software & Services
  • 2.1.7 Infectious Disease
  • 2.1.8 Auto Immune
  • 2.1.9 Endocrinology
  • 2.1.10 Oncology
  • 2.1.11 Cardiology
  • 2.1.12 Other Specialty
• 2.2 Market Definition
  • 2.2.1 Market Sizes
  • 2.2.2 Currency
  • 2.2.3 Years
• 2.3 Methodology
  • 2.3.1 Methodology
  • 2.3.2 Sources
  • 2.3.3 Authors
• 2.4 Perspective: Healthcare and the IVD Industry
  • 2.4.1 Global Healthcare Spending
  • 2.4.2 Spending on Diagnostics
  • 2.4.3 Important Role of Insurance for Diagnostics

3 Industry Overview

• 3.1 Players in a Dynamic Market
  • 3.1.1 Academic Research Lab
  • 3.1.2 Diagnostic Test Developer
  • 3.1.3 Instrumentation Supplier
  • 3.1.4 Chemical/Reagent Supplier
  • 3.1.5 Pathology Supplier
  • 3.1.6 Independent Clinical Laboratory
  • 3.1.7 Public National/regional Laboratory
  • 3.1.8 Hospital Laboratory
  • 3.1.9 Physicians Office Lab (POLS)
  • 3.1.10 Audit Body
  • 3.1.11 Certification Body
• 3.2 The Clinical Laboratory Market Segments
  • 3.2.1 Traditional Market Segmentation
  • 3.2.2 Laboratory Focus and Segmentation
  • 3.2.3 Hospital Testing Share
  • 3.2.4 Economies of Scale
  • 3.2.5 Hospital vs. Central Lab
  • 3.2.6 Physician Office Lab's
  • 3.2.7 Physician's and POCT
• 3.3 Immunoassay - Markets and Discussion
  • 3.3.1 Instruments - Genetics changes the picture
    • 3.3.1.1 RIA - A Technology Shows its Age
    • 3.3.1.2 Immunoassay vs. PCR vs. Sequencing - A See Saw Battle
    • 3.3.1.3 The Smart Shrinking Instrument - Serious Implications
    • 3.3.1.4 Research Funding and Capital Expense - Instrument Pooling
    • 3.3.1.5 Multiplex vs. POC - A Tradeoff Analysis
  • 3.3.2 Reagents and Kits - Genetics changes the picture
    • 3.3.2.1 Bigger Test Menus a Boon for Kit Market
    • 3.3.2.2 Physician Office Labs - A New Frontier
  • 3.3.3 Rapid and POCT to Threaten Instrument Markets
  • 3.3.4 OTC and DTC - Huge Market Potential
  • 3.3.5 Economies of Scale. Going Away?
  • 3.3.6 Lower Barriers to Entry for Instruments/Analyzers
  • 3.3.7 Miniturization and Technology Drive Acquisition

4 Market Trends

• 4.1 Factors Driving Growth
  • 4.1.1 Diagnostic Factors
  • 4.1.2 Changing Technologies Spur Early Instrument Retirement
  • 4.1.3 Consumer Channels Open Wider
  • 4.1.4 Immunity Technology Comes of Age
• 4.2 Factors Limiting Growth
  • 4.2.1 Increased Competition Lowers Price
  • 4.2.2 Threat from PCR Based Instruments
  • 4.2.3 Lower Barriers to Entry
  • 4.2.4 Wellness has a downside
• 4.3 Immunoassay Instrumentation
  • 4.3.1 Instrumentation Tenacity
  • 4.3.2 Declining Cost of Instruments Changes Industry Structure
  • 4.3.3 Immunoassay - CRISPR Diagnostics

5 Immunoassay Recent Developments

• 5.1 Recent Developments - Importance and How to Use This Section
  • 5.1.1 Importance of These Developments
  • 5.1.2 How to Use This Section
• 5.2 Beckman Coulter Dx Analyzer Gets FDA Clearance
• 5.3 Cubit Diagnostics Gets NIH Funding for Test on Multimodal Platform
• 5.4 Medix Biochemica Acquires Candor Bioscience
• 5.5 Siemens Healthineers Dx Business Poised for Growth
• 5.6 QuidelOrtho Stock Upgraded
• 5.7 AliveDx Gets CE Mark for Allergy Immunoassay
• 5.8 FDA Grants EAU for At-Home COVID, Flu Assay
• 5.9 Single-Molecule Detection Tech Shows Promise
• 5.10 QuidelOrtho Vitros Fentanyl Test
• 5.11 Labcorp: Plasma Phosphorylated-Tau 217
• 5.12 Renalytix Gets Immunoassay Medicare Coverage
• 5.13 Roche to Acquire LumiraDx POC Tech
• 5.14 Fujirebio, Sysmex to Collaborate on Immunoassay Development
• 5.15 EDP Biotech, New Day Diagnostics to Merge
• 5.16 Sorrento Therapeutics Nabs Contract for Dx Platform
• 5.17 Beckman Coulter Diagnostics DxI 9000 Access Immunoassay Analyzer
• 5.18 Qorvo Eyes Multiplex Immunoassay
• 5.19 BioMerieux Launches New Products
• 5.20 Senzo to Commercialize Infectious Disease Lateral Flow Tests
• 5.21 Nanomix Plans Instrument, Test Launches
• 5.22 Startup GLX Analytix Prepares for Commercialization
• 5.23 Nonagen Gets CE Mark for Bladder Cancer Immunoassay
• 5.24 Qualigen Acquires Majority Stake in NanoSynex
• 5.25 Saladax Biomedical Using Immunoassay Dx
• 5.26 Prolight Diagnostics to Acquire Psyros Diagnostics
• 5.27 Quidel to Acquire Ortho Clinical Diagnostics

6 Profiles of Key Companies

• 6.1 Abbott Laboratories
• 6.2 Abcam
• 6.3 Abionic
• 6.4 Accel Diagnostics
• 6.5 Agilent
• 6.6 Akonni Biosystems
• 6.7 Applied BioCode
• 6.8 Arlington Scientific
• 6.9 Arrayit Corporation
• 6.10 Atomo Diagnostics
• 6.11 Aureum Diagnostics
• 6.12 Aurora Biomed
• 6.13 Autobio Diagnostics
• 6.14 AVIVA Systems Biology
• 6.15 Awareness Technology
• 6.16 Axis-Shield Diagnostics Ltd.
• 6.17 Beckman Coulter Diagnostics (Danaher)
• 6.18 Becton, Dickinson and Company
• 6.19 Biocartis
• 6.20 Biomatik
• 6.21 bioMerieux Diagnostics
• 6.22 Bioneer Corporation
• 6.23 Bio-Rad Laboratories, Inc.
• 6.24 Bio-Synthesis
• 6.25 Bio-Techne
• 6.26 Boditech Med, Inc
• 6.27 Boster Biological Technology
• 6.28 Bruker
• 6.29 Cerstest Biotec
• 6.30 Chembio
• 6.31 CTK Biotech
• 6.32 Cue Health
• 6.33 Cytena
• 6.34 Diasorin S.p.A.
• 6.35 Dynex Technologies
• 6.36 Eiken Chemical
• 6.37 Enzo Biochem
• 6.38 Eurofins Scientific
• 6.39 Fluxion Biosciences (Cell Microsystems)
• 6.40 FUJIFILM Wako Diagnostics
• 6.41 Fujirebio
• 6.42 Global Access Diagnostics
• 6.43 Gold Standard Diagnostics
• 6.44 Greiner Bio-One
• 6.45 Grifols
• 6.46 Hycor Biomedical
• 6.47 Immunodiagnostic Systems (IDS)
• 6.48 Iollo
• 6.49 JR Biomedical
• 6.50 LightDeck Diagnostics
• 6.51 LumiraDx
• 6.52 Maxim Biomedical
• 6.53 Meso Scale Discovery
• 6.54 Millipore Sigma
• 6.55 Mindray
• 6.56 Molecular Devices
• 6.57 MP Biomedical
• 6.58 Operon
• 6.59 OraSure Technologies
• 6.60 Qiagen
• 6.61 QuidelOrtho
• 6.62 R&D Systems
• 6.63 Randox Toxicology
• 6.64 R-Biopharm AG
• 6.65 Response Biomedical
• 6.66 Revvity
• 6.67 Roche Diagnostics
• 6.68 SD Biosensor
• 6.69 Siemens Healthineers
• 6.70 Standard BioTools
• 6.71 Sysmex
• 6.72 Tecan
• 6.73 Thermo Fisher Scientific
• 6.74 TOSOH Bioscience
• 6.75 Uniogen
• 6.76 Veramarx
• 6.77 Veredus Laboratories
• 6.78 Vircell
• 6.79 Wantai Biopharm
• 6.80 Werfen
• 6.81 YD Diagnostics
• 6.82 Zhejiang Orient Gene Biotech

7 The Global Market

• 7.1 Global Market by Country
  • 7.1.1 Global Market by Country Table
  • 7.1.2 Global Market by Country Chart
• 7.2 Global Market by Application
  • 7.2.1 Global Market by Application Table
  • 7.2.2 Global Market by Application Segment Growth Chart
  • 7.2.3 Global Market by Application Segment Annual Chart
  • 7.2.4 Global Market by Application Segment Base vs. Final
  • 7.2.5 Global Market by Application Base Year
  • 7.2.6 Global Market by Application Final Year
• 7.3 Global Market by Technology
  • 7.3.1 Global Market by Technology Table
  • 7.3.2 Global Market by Technology Segment Growth Chart
  • 7.3.3 Global Market by Technology Segment Annual Chart
  • 7.3.4 Global Market by Technology Segment Base vs. Final
  • 7.3.5 Global Market by Technology Base Year
  • 7.3.6 Global Market by Technology Final Year
• 7.4 Global Market by Product
  • 7.4.1 Global Market by Product Table
  • 7.4.2 Global Market by Product Segment Growth Chart
  • 7.4.3 Global Market by Product Segment Annual Chart
  • 7.4.4 Global Market by Product Segment Base vs. Final
  • 7.4.5 Global Market by Product Base Year
  • 7.4.6 Global Market by Product Final Year
• 7.5 Global Market by User
  • 7.5.1 Global Market by User Table
  • 7.5.2 Global Market by User Segment Growth Chart
  • 7.5.3 Global Market by User Segment Annual Chart
  • 7.5.4 Global Market by User Segment Base vs. Final
  • 7.5.5 Global Market by User Base Year
  • 7.5.6 Global Market by Application Final Year

8 Global Market by Application

• 8.1 Endocrinology Applications
  • 8.1.1 Endocrinology Applications by Country Table
  • 8.1.2 Endocrinology Applications Growth Chart
• 8.2 Immune Applications
  • 8.2.1 Immune Applications by Country Table
  • 8.2.2 Immune Applications Growth Chart
• 8.3 Oncology Applications
  • 8.3.1 Oncology Applications by Country Table
  • 8.3.2 Oncology Applications Growth Chart
• 8.4 Infectious Disease Applications
  • 8.4.1 Infectious Disease Applications by Country Table
  • 8.4.2 Infectious Disease Applications Growth Chart
• 8.5 Cardiology Applications
  • 8.5.1 Cardiology Applications by Country Table
  • 8.5.2 Cardiology Applications Growth Chart
• 8.6 Other Applications
  • 8.6.1 Other Applications by Country Table
  • 8.6.2 Other Applications Growth Chart

9 Immunoassay by Technology

• 9.1 Enzyme
  • 9.1.1 Enzyme by Country Table
  • 9.1.2 Enzyme Growth Chart
• 9.2 Flourescence
  • 9.2.1 Flourescence by Country Table
  • 9.2.2 Flourescence Growth Chart
• 9.3 Chemiluminescence
  • 9.3.1 Chemiluminescence by Country Table
  • 9.3.2 Chemiluminescence Growth Chart
• 9.4 Nucleic Acid
  • 9.4.1 Nucleic Acid by Country Table
  • 9.4.2 Nucleic Acid Growth Chart
• 9.5 Rapid/POC
  • 9.5.1 Rapid/POC by Country Table
  • 9.5.2 Rapid/POC Growth Chart
• 9.6 Other Technology
  • 9.6.1 Other Technology by Country Table
  • 9.6.2 Other Technology Growth Chart

10 Immunoassay by Product

• 10.1 Instrument
  • 10.1.1 Instrument by Country Table
  • 10.1.2 Instrument Growth Chart
• 10.2 Reagents
  • 10.2.1 Reagents by Country Table
  • 10.2.2 Reagents Growth Chart
• 10.3 Services
  • 10.3.1 Services by Country Table
  • 10.3.2 Services Growth Chart

11 Immunoassay by User

• 11.1 Hospital
  • 11.1.1 Hospital by Country Table
  • 11.1.2 Hospital Growth Chart
• 11.2 Outpatient Lab
  • 11.2.1 Outpatient Lab by Country Table
  • 11.2.2 Outpatient Lab Growth Chart
• 11.3 POC/Other
  • 11.3.1 POC/Other by Country Table
  • 11.3.2 POC/Other Growth Chart

12 Vision of the Future of Immunoassay

13 Appendices

• 13.1 Growth of Approved IVD Test Menu
• 13.2 Growth of Approved Average IVD Test Fee
• 13.3 The Most Used IVD Assays
• 13.4 The Highest Grossing Assays
• 13.5 Laboratory Fees Schedule

Table of Tables

• Table 1 Market Players by Type
• Table 2 Clinical Laboratory Departments and Segments
• Table 3 Laboratory Management Focus - Different Approaches
• Table 4 Key Segmentation Variables Going Forward
• Table 5 The Different Markets for Immunoassay
• Table 6 The Factors Driving Growth
• Table 7 Factors Limiting Growth
• Table 8 The Global Immunoassay Market by Country
• Table 9 Global Market by Application
• Table 10 Global Market by Technology
• Table 11 Global Market by Product
• Table 12 Global Market by User
• Table 13 Endocrinology Immunoassay by Country
• Table 14 Immune Immunoassay by Country
• Table 15 Oncology Immunoassay by Country
• Table 16 Infectious Disease Immunoassay by Country
• Table 17 Cardiology Immunoassay by Country
• Table 18 Other Immunoassay by Country
• Table 19 Enzyme Immunoassay by Country
• Table 20 Flourescence Immunoassay by Country
• Table 21 Chemiluminescence Immunoassay by Country
• Table 22 Nucleic Acid Immunoassay by Country
• Table 23 Rapid/POC Immunoassay by Country
• Table 24 Other Technology Immunoassay by Country
• Table 25 Instrument by Country
• Table 26 Reagents by Country
• Table 27 Services by Country
• Table 28 Hospital Usrr by Country
• Table 29 Outpatient Lab by Country
• Table 30 POC/Other by Country
• Table 31 The Most Common Assays
• Table 32 Largest Revenue Assays
• Table 33 Clinical Lab Fee Schedule

Table of Figures

• Figure 1 Global Healthcare Spending
• Figure 2 The Lab Test Pie
• Figure 3 The Road to Diagnostics
• Figure 4 Immunoassay - Country Sharea
• Figure 5 Chart of Growth by Application
• Figure 6 Chart of Segment by Year
• Figure 7 Chart of Base vs. Final
• Figure 8 Chart of Base Year by Application
• Figure 9 Chart of Final Year by Application
• Figure 10 Chart of Growth by Technology
• Figure 11 Chart of Technology Segment by Year
• Figure 12 Chart of Technology Base vs. Final
• Figure 13 Chart of Base Year by Technology
• Figure 14 Chart of Final Year by Technology
• Figure 15 Chart of Growth by Product
• Figure 16 Chart of Product Segment by Year
• Figure 17 Chart of Product Base vs. Final
• Figure 18 Chart of Base Year by Product
• Figure 19 Chart of Final Year by Product
• Figure 20 Chart of Growth by User
• Figure 21 Chart of User Segment by Year
• Figure 22 Chart of User Base vs. Final
• Figure 23 Chart of Base Year by User
• Figure 24 Chart of Final Year by User
• Figure 25 Chart - Endocrine Segment vs Total Market Growth
• Figure 26 Chart - Immune Growth vs. Total
• Figure 27 Chart - Oncology vs Total
• Figure 28 Chart - Infectious Disease Immunoassay vs Total
• Figure 29 Chart - Cardiology Immunoassay vs total
• Figure 30 Chart - Other Immunoassay vs Total
• Figure 31 Chart - Enzyme Segment vs Total Market Growth
• Figure 32 Chart - Flourescence Growth vs. Total
• Figure 33 Chart - Chemiluminescence vs Total
• Figure 34 Chart - Nucleic Acid Immunoassay vs Total
• Figure 35 Chart - Rapid/POC Immunoassay vs total
• Figure 36 Chart - Other Technology Immunoassay vs Total
• Figure 37 Chart - Instrument Segment vs Total Market Growth
• Figure 38 Chart - Reagents Growth vs. Total
• Figure 39 Chart - Services vs Total
• Figure 40 Chart - Hospital Segment vs Total Market Growth
• Figure 41 Chart - Outpatient Lab Growth vs. Total
• Figure 42 Chart - POC/Other vs Total
• Figure 43 IVD Test Menu Growth
• Figure 44 IVD Test Average Fees - A Ten Year View